Symbols

NVCN(Delisted)

Neovasc·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NVCN

Neovasc Inc.

A developer of minimally invasive medical devices for the cardiovascular market

Industry

Established Date

11/02/2000

Listing Date

05/21/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.neovasc.com

Security Type

Common stock

Office address

Suite 5138 – 13562 Maycrest Way, Richmond, British Columbia, Canada V6V 2J7

Business

Introduction

Neovasc Inc., a professional medical device company, develops, manufactures and sells products for the rapidly growing cardiovascular market. Its products include headgear (" Crown ") for the development of interventional therapy technology for mitral valve disease, reducer for Neiovask for the treatment of intractable angina pectoris (" deceleration ") and a product line of advanced biological tissue called peripatch (called "peripatch ") as third-party medical products, including key components of transcatheter heart valves. The company was incorporated as a medical company under the Company Act (British Columbia) on November 2, 2000 and is a Canadian business enterprise with a continuing role on April 19, 2002. On July 1, 2008, the company changed its name to Neovasc Inc.

Company Financials

EPS

NVCN has released its 2022 Q4 earnings. EPS was reported at -5.04, versus the expected -2.71, missing expectations. The chart below visualizes how NVCN has performed over recent quarters, highlighting trends in earnings surprises.